Estratificación del riesgo y tratamiento de la colangitis biliar primaria
- Javier Martínez González 1
- Lara Aguilera Castro 1
- Agustín Albillos Martínez 1
- 1 Hospital Universitario Ramón y Cajal. Madrid
ISSN: 2340-416, 1130-0108
Year of publication: 2019
Volume: 111
Issue: 1
Pages: 63-70
Type: Article
More publications in: Revista Española de Enfermedades Digestivas
Abstract
Primary biliary cholangitis is a chronic liver disorder characterized by progressive cholestasis that may evolve to liver cirrhosis. While ursodeoxycholic acid is the treatment of choice, around 30% of patients do not respond to this therapy. These patients have a poorer prognosis, hence should be identified early in order to be offered therapy options. Along these lines, improved understanding of the condition's pathophysiology has allowed the development of newer drugs, including obeticholic acid and fibrates. This review offers a perspective on risk stratification and treatment for these patients, from ursodeoxycholic acid to second-line treatments.